Oklahoma City: Biomanufacturing Workforce Training Center

“This training facility positions OKC as one of the few biomanufacturing talent centers in the United States, in addition to state advantages in cost, location, and infrastructural advantages,” said Dallas Browning, research and investment partner at Echo Investment Capital. “This will attract business expansion and new direct investment in biomanufacturing, further grow the industry in Oklahoma, and fuel the continued development of existing businesses in the region, such as , creating hundreds of new, non-degree paying jobs. at or above the region’s median income.

The BWTC will impact the research already done by Cytovance and help attract more companies to Oklahoma City, according to Stephanie Wickham, the company’s senior director of research and development.

“The Biofabrication Workforce Training Center will provide researchers with technicians already trained in the basic laboratory skills needed to get started,” Wickham said. “With this, research labs won’t have to do as much on-the-job training and will be able to generate data sooner, leading to the launch of new offerings sooner, which is more attractive to industry. The sooner our researchers can obtain essential data for grant applications, the sooner we can be seen as a hub for science and innovation.

“I believe the Oklahoma City BWTC will play a central role in the recent executive order, and Oklahoma is strategically located in the middle of the United States to be able to service both coasts of the country equally, while maintaining a low operating cost,” Wickham added. “Having a workforce ready to connect to industry will be attractive to companies looking to build here.”

Wheeler Bio CEO and co-founder Jesse McCool agrees that the BWTC program has the potential to help position Oklahoma City as a national hub for biomanufacturing.

“An industry shift toward entrepreneurial discovery and development is underway in biomanufacturing, with emerging biopharmaceutical companies now responsible for 90% of next-generation product discovery and development,” McCool said. “OKC’s Biomanufacturing Workforce Training Center is fortunate to fill a gap in the region’s biomanufacturing process by providing a missing piece to the region’s puzzle; Full integration across the product development lifecycle – uniting regional research, manufacturing, clinical trials, and more. – could provide a frictionless and cost-effective environment for global drug developers. This gives Central American ecosystems a unique advantage to compete with established coastal leaders, and because of Oklahoma City’s natural advantages (cost, location, existing infrastructure, and business advantage), the city is well positioned to meet the needs above, as it seeks to evolve its workforce with the BWTC.

The BWTC is one of six major investment projects designed to grow the region’s biotech industry, build national resilience within the biopharmaceutical supply chain and make the cluster more globally competitive. . The five additional core investment projects, most of which are centered in the heart of the OKC Innovation District, are:

Milton S. Rodgers